uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences

We recently published 10 Stocks on a Hot Streak. uniQure NV (NASDAQ:QURE) is one of the best-performing stocks on Tuesday.

uniQure soared by 17.93 percent on Tuesday to close at $30.84 apiece as investors repositioned portfolios ahead of two healthcare conferences this week.

In an updated report, uniQure NV (NASDAQ:QURE) said that it would participate in the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston, Massachusetts, on Wednesday, November 12, as well as the Stifel 2025 Healthcare Conference in New York on Thursday, November 13.

On Monday, uniQure NV (NASDAQ:QURE) announced the results of its earnings performance in the third quarter of the year, where it widened its net loss by 81 percent to $80.5 million from $44.4 million in the same period last year.

Total revenues jumped by 61 percent to $3.7 million from $2.29 million year-on-year, on the back of a $1.5 million increase in license revenues, which offset a decrease in collaboration revenues.

Also in the third quarter, uniQure NV (NASDAQ:QURE) reported positive topline data from the pivotal phase 1/2 study for its AMT-130 treatment candidate for Huntington’s disease.

Based on its latest results, enrolled patients who were given the treatment saw a significant 75 percent slowdown in disease progression without any serious adverse reactions.

Last month, the company met with the Food and Drug Administration to discuss its plan to submit a Biologics License Application. However, the agency appeared lukewarm on the results.

The company said it has yet to receive a formal notice from the FDA, but said that it is working closely with the agency to discuss measures to move forward.

While we acknowledge the risk and potential of QURE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than QURE and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.